N,N-dialkyl-dipeptidylamines as novel N-type calcium channel blockers

被引:19
|
作者
Hu, LY
Ryder, TR
Rafferty, MF
Cody, WL
Lotarski, SM
Miljanich, GP
Millerman, E
Rock, DM
Song, YT
Stoehr, SJ
Taylor, CP
Weber, ML
Szoke, BG
Vartanian, MG
机构
[1] Parke Davis Pharmaceut Res, Ann Arbor, MI 48105 USA
[2] Elan Pharmaceut Inc, Menlo Park, CA 94025 USA
关键词
D O I
10.1016/S0960-894X(99)00100-6
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Selective N-type voltage sensitive calcium channel (VSCC) blockers have shown utility in several models of stroke amid pain. We are especially interested in small molecule N-type calcium channel blockers for therapeutic use. Herein, we report a series of N,N-dialkyl-dipeptidylamines with potent functional activity at N-type VSCCs and in vivo efficacy. The synthesis, SAR, and pharmacological evaluation of this series are discussed. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:907 / 912
页数:6
相关论文
共 50 条
  • [31] N-type Calcium Channel Blocker for Pain Treatment
    Mao, Jianren
    PAIN MEDICINE, 2010, 11 (02) : 153 - 153
  • [32] N-type calcium channel blockade in diabetic nephropathy
    Fujisawa, Tomomi
    Ikegami, Hiroshi
    Noso, Shisuke
    Hiromine, Yoshihisa
    Kawabata, Yumiko
    Asano, Katsuaki
    Nojima, Koji
    Fukai, Aya
    Shindo, Nobuyasu
    Ogihara, Toshio
    JOURNAL OF HYPERTENSION, 2006, 24 : 225 - 225
  • [33] Synthesis and biological evaluation of substituted 4-(OBz)phenylalanine derivatives as novel N-type calcium channel blockers
    Hu, LY
    Ryder, TR
    Nikam, SS
    Millerman, E
    Szoke, BG
    Rafferty, MF
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (08) : 1121 - 1126
  • [34] The N-type calcium channel is a novel target for treating alcohol use disorders
    Newton, Philip M.
    Messing, Robert O.
    CHANNELS, 2009, 3 (02) : 77 - 81
  • [35] Hit to lead studies on pyrazoles as novel N-type calcium channel inhibitors
    Winters, Michael P.
    Subasinghe, Nalin
    Wall, Mark
    Qin, Ning
    Lubin, Mary Lou
    Finley, Michael
    Neeper, Michael P.
    Flores, Christopher M.
    Sui, Zhihua
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [36] Comparative QSAR study on a novel class of N-type calcium channel blocks
    Ouyang Liang
    He Gu
    Guo Li
    ACTA CHIMICA SINICA, 2006, 64 (13) : 1379 - 1384
  • [37] Evolving therapeutic indications for N-type calcium channel blockers: from chronic pain to alcohol abuse
    Belardetti, Francesco
    FUTURE MEDICINAL CHEMISTRY, 2010, 2 (05) : 791 - 802
  • [38] PD 151307 analogs: Investigation of tyrosine(OBz) modified derivatives as N-type calcium channel blockers
    Chatterjee, A
    Booth, J
    Brogley, L
    Campbell, G
    Cody, W
    Geer, JJ
    He, J
    Hu, LY
    Lescosky, LJ
    Malone, T
    Miljanich, G
    Nadasch, L
    Rafferty, MF
    Rock, D
    Sercel, A
    Silva, D
    Stoehr, S
    Song, YT
    Szoke, BG
    Tarezy-Ilornoch, K
    Taylor, C
    Urge, L
    Weber, M
    Vartanian, M
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1999, 217 : U1190 - U1190
  • [39] N-type calcium channel blockers from a marine bacterium, Cytophaga sp. SANK 71996
    Morishita, T
    Sato, A
    Hisamoto, M
    Oda, T
    Matsuda, K
    Ishii, A
    Kodama, K
    JOURNAL OF ANTIBIOTICS, 1997, 50 (06): : 457 - 468
  • [40] Synthesis and structure activity relationship of substituted quinoline and isoquinoline derivatives as N-type calcium channel blockers
    Yuen, PW
    Schelkun, RM
    Szoke, B
    TarczyHornoch, K
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1997, 214 : 5 - MEDI